While artificial intelligence (AI) holds promise to improve the diagnosis of melanoma, researchers of a new review outlined ...

Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.

A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps ...

Have you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...

Theresa Medina, MD, associate professor of medicine-medical oncology at the University of Colorado Cancer Center, Anschutz ...

Patients with early-stage melanoma who experience relapse following wide local excision face worse survival outcomes.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Mismatch repair germline alterations occur frequently in uveal melanoma, suggesting it could be part of the Lynch syndrome spectrum.

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

Risk factors associated with emergency presentations following malignant skin cancer. Expanding the genetic code in mammalian cells using pseudouridine modified codons.